Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Core histone macro-H2A.1 (MACROH2A1) is a histone variant distinguished by its tripartite structure: a histone fold domain (similar to canonical H2A), an intrinsically disordered linker, and a large C-terminal macrodomain. Alternative splicing creates two main isoforms, macroH2A1.1 and macroH2A1.2, which have opposing biological functions due to differences in macrodomain ligand binding (macroH2A1.1 binds ADP-ribose, macroH2A1.2 does not). MacroH2A1 is involved in chromatin compaction, transcriptional repression, nuclear organization, and the regulation of cellular metabolism, notably through direct inhibition of PARP1, affecting NAD+ metabolism and DNA repair. It is highly conserved and enriched at transcriptionally silent chromatin domains such as the inactive X chromosome in female mammals, acting as an epigenetic barrier to pluripotency and tumor progression. Loss of macroH2A1 is associated with increased chromatin plasticity and tumor progression, while its presence limits chromatin remodeling, transcriptional noise, and promotes robust gene expression programs.
MacroH2A1.1 binds to ADP-ribose and inhibits PARP1 enzymatic activity, thereby affecting NAD+ metabolism, DNA repair, and gene regulation. It recruits histone deacetylases (HDACs) and modulates the acetylation status of chromatin, contributing to transcriptional repression. Its incorporation into chromatin alters nucleosome structure, making chromatin less accessible and more refractory to remodeling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Core histone macro-H2A.1 (MACROH2A1).